There are currently 44 active clinical trials seeking participants for Peripheral Arterial Disease research studies. The states with the highest number of trials for Autism participants are Texas, Florida, California and Illinois.
Pounce™ Thrombectomy System Retrospective Registry
Recruiting
The PROWL registry is an open-label retrospective, multi-center, US study of the Surmodics™ Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/18/2024
Locations: OSF St. Francis Medical Center, Peoria, Illinois +7 locations
Conditions: Peripheral Arterial Disease, Acute Limb Ischemia
SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs
Recruiting
A research project capturing experiences of patients with critical limb threatening ischemia, with the ultimate goal of setting new standards for diagnosing, describing detailed patient-centered outcomes, and evaluating the variability in therapeutic approaches and their association with outcomes.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/09/2024
Locations: Yale New Haven Health, New Haven, Connecticut
Conditions: Peripheral Arterial Disease
A Study of Loco-Regional Liposomal Bupivacaine Injection
Recruiting
The purpose of this research is to find out if using liposomal bupivacaine solution (bupivacaine liposome) injections during lower extremity revascularization surgery will lower the amount of narcotic drugs used during and following the procedure.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/05/2024
Locations: Mayo Clinic Health System - Eau Claire, Eau Claire, Wisconsin
Conditions: Peripheral Arterial Disease
Carnosine for Peripheral Arterial Disease Patients
Recruiting
Oral supplementation of L-carnosine will increase muscle carnosine, stabilize HIF1-alpha promote angiogenesis, and thus improve the functioning of lower extremities in PAD patients.
Gender:
Male
Ages:
Between 50 years and 80 years
Trial Updated:
04/05/2024
Locations: University of Louisville, Louisville, Kentucky
Conditions: Peripheral Arterial Disease
SELUTION4SFA Trial
Recruiting
This study aims to demonstrate the safety and efficacy of the SELUTION SLR™ 018 DEB compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).
Gender:
All
Ages:
18 years and above
Trial Updated:
03/14/2024
Locations: Honor Health Research and Innovation Institute, Scottsdale, Arizona +31 locations
Conditions: Peripheral Arterial Disease, Superficial Femoral Artery Stenosis
SELUTION4BTK Trial
Recruiting
This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/12/2024
Locations: St. Bernards Medical Center, Jonesboro, Arkansas +35 locations
Conditions: Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
Tack Optimized Balloon Angioplasty Post-Market Study
Recruiting
The objective of this study is to obtain outcomes following dissection repair with the Tack Endovascular System in a broad population of patients undergoing endovascular treatment of lesions within the superficial femoral, popliteal, peroneal, and/or tibial arteries.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/11/2024
Locations: Advanced Heart and Vein Center - Thornton, Thornton, Colorado +9 locations
Conditions: PAD - Peripheral Arterial Disease, PAD, Dissection, Arterial Dissection, Peripheral Arterial Disease, Peripheral Vascular Diseases
SPECT/CT Imaging of Skeletal Muscle Perfusion
Recruiting
This study will use SPECT/CT imaging to assess the effect of percutaneous revascularization treatments in patients with Peripheral arterial disease and diabetes mellitus, in whom the disease can progress more quickly than in patients without diabetes.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/09/2024
Locations: Yale-New Haven Hospital, New Haven, Connecticut
Conditions: Peripheral Arterial Disease, Diabetes Mellitus
The ROAMM-EHR Study
Recruiting
In recent years, mobile health (mHealth) apps have promised improved monitoring of health conditions to improve clinical outcomes. The objective of this study is to conduct a pilot randomized clinical trial (RCT) to evaluate the impact of using remotely collected patient generated health data (PGHD) from older patients undergoing bypass surgery due to chronic limb threatening ischemia. The hypothesis is that integrating PGHD with an EHR system will help providers manage post-surgical symptoms an... Read More
Gender:
All
Ages:
Between 60 years and 100 years
Trial Updated:
02/09/2024
Locations: Institute of Aging, Gainesville, Florida
Conditions: Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Recruiting
A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.
Gender:
All
Ages:
Between 18 years and 95 years
Trial Updated:
02/05/2024
Locations: UCSF, San Francisco, California +19 locations
Conditions: Critical Limb Ischemia, Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia
A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)
Recruiting
This is a prospective, multicenter, single arm study designed to evaluate the safety and efficacy of the Temporary Bare Spur Stent System (Spur Stent System).
Gender:
All
Ages:
18 years and above
Trial Updated:
01/26/2024
Locations: St. Bernards Heart and Vascular, Jonesboro, Arkansas +31 locations
Conditions: Peripheral Arterial Disease, Critical Limb Ischemia
CRUSH PAD: Real-world Outcomes Following Use of the Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
Recruiting
The primary goal of the study is to obtain effect size data on the use of Shockwave Intravascular Lithotripsy (IVL) technology in calcified common femoral lesions in patients with peripheral artery disease for a series of endpoints, including target lesion revascularization and health status, to enable future planning of comparative effectiveness research.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/25/2024
Locations: Yale New Haven Health, New Haven, Connecticut
Conditions: Femoral Arterial Calcification, Peripheral Arterial Disease, Claudication, Critical Limb Ischemia